XML 32 R22.htm IDEA: XBRL DOCUMENT v3.25.3
Inventories (Tables)
9 Months Ended
Sep. 30, 2025
Inventory Disclosure [Abstract]  
Schedule of inventory, current
At September 30, 2025 and December 31, 2024, the Company's net inventories consisted of the following:
September 30, 2025December 31, 2024
Raw materials and work in process$9,747,221 $11,982,045 
Consigned inventory51,288 126,090 
Finished goods2,320,076 2,897,359 
Total inventories12,118,585 15,005,494 
less non-current inventories(9,183,862)(11,005,499)
Total inventories classified as current$2,934,723 $3,999,995 
Schedule of inventory, noncurrent
At September 30, 2025 and December 31, 2024, the Company's non-current inventories consisted of the following:
September 30, 2025December 31, 2024
Vibativ Raw Materials$4,714,922 $6,180,347 
Kristalose Raw Materials2,362,712 2,672,720 
Vaprisol Raw Materials1,173,070 1,172,849 
Sancuso Raw Materials285,153 458,684 
Caldolor Raw Materials16,982 — 
Acetadote Raw Materials42,718 23,915 
Ifetroban Raw Materials65,270 166,923 
Kristalose Finished Goods177,715 — 
Vibativ Finished Goods157,477 183,057 
Caldolor Finished Goods118,221 77,382 
Omeclamox-Pak Raw Materials69,622 69,622 
Total inventories classified as non-current$9,183,862 $11,005,499